RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.040
-0.120 (-10.34%)
Nov 13, 2026, 4:00 PM EST - Market closed
RenovoRx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.4 | 7.02 | 7.15 | 1.17 | 4.39 | 15.19 |
Short-Term Investments | - | - | - | - | 2.05 | - |
Cash & Short-Term Investments | 10.4 | 7.02 | 7.15 | 1.17 | 6.44 | 15.19 |
Cash Growth | 3.58% | -1.82% | 509.89% | -81.79% | -57.61% | 746.35% |
Receivables | 0.61 | 0.14 | 0.04 | - | - | - |
Inventory | 0.34 | 0.19 | - | - | - | - |
Prepaid Expenses | 0.27 | 0.32 | 0.33 | 0.17 | 0.83 | 1.09 |
Other Current Assets | 0.2 | 0.22 | 0.3 | 0.13 | - | - |
Total Current Assets | 11.81 | 7.89 | 7.83 | 1.47 | 7.27 | 16.28 |
Property, Plant & Equipment | 0.42 | 0.2 | 0.29 | - | - | 0.01 |
Other Long-Term Assets | 0.2 | - | - | - | - | - |
Total Assets | 12.44 | 8.1 | 8.12 | 1.47 | 7.27 | 16.29 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.94 | 0.8 | 0.59 | 0.56 | 0.53 | 0.53 |
Accrued Expenses | 1.15 | 1.06 | 1.26 | 0.61 | 0.57 | 0.41 |
Current Portion of Leases | - | 0.11 | 0.07 | - | - | - |
Total Current Liabilities | 2.09 | 1.96 | 1.91 | 1.18 | 1.1 | 0.94 |
Long-Term Leases | 0.23 | 0.11 | 0.21 | - | - | - |
Other Long-Term Liabilities | 0.84 | 0.6 | 1.52 | 3.29 | - | - |
Total Liabilities | 3.15 | 2.67 | 3.64 | 4.47 | 1.1 | 0.94 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 80.75 | 66.81 | 54.7 | 38.4 | 37.32 | 36.63 |
Retained Earnings | -71.47 | -61.39 | -50.22 | -41.41 | -31.17 | -21.28 |
Comprehensive Income & Other | - | - | - | - | 0.02 | - |
Total Common Equity | 9.28 | 5.42 | 4.48 | -3 | 6.16 | 15.35 |
Shareholders' Equity | 9.28 | 5.42 | 4.48 | -3 | 6.16 | 15.35 |
Total Liabilities & Equity | 12.44 | 8.1 | 8.12 | 1.47 | 7.27 | 16.29 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.23 | 0.21 | 0.28 | - | - | - |
Net Cash (Debt) | 10.18 | 6.81 | 6.88 | 1.17 | 6.44 | 15.19 |
Net Cash Growth | 3.78% | -0.93% | 486.19% | -81.79% | -57.61% | - |
Net Cash Per Share | 0.24 | 0.19 | 0.31 | 0.11 | 0.71 | 2.91 |
Filing Date Shares Outstanding | 48.25 | 45.05 | 36.55 | 16.87 | 9.1 | 9.03 |
Total Common Shares Outstanding | 48.19 | 36.61 | 24.03 | 10.69 | 9.1 | 8.93 |
Working Capital | 9.72 | 5.93 | 5.92 | 0.29 | 6.16 | 15.34 |
Book Value Per Share | 0.19 | 0.15 | 0.19 | -0.28 | 0.68 | 1.72 |
Tangible Book Value | 9.28 | 5.42 | 4.48 | -3 | 6.16 | 15.35 |
Tangible Book Value Per Share | 0.19 | 0.15 | 0.19 | -0.28 | 0.68 | 1.72 |